IRIS
AMATI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.673
AS - Asia 1.569
EU - Europa 554
SA - Sud America 228
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 37
OC - Oceania 11
Totale 4.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.606
SG - Singapore 876
CN - Cina 359
BR - Brasile 192
IT - Italia 143
VN - Vietnam 130
FI - Finlandia 87
IE - Irlanda 63
DE - Germania 62
GB - Regno Unito 56
IN - India 47
HK - Hong Kong 42
SE - Svezia 33
CA - Canada 32
BD - Bangladesh 26
RU - Federazione Russa 26
FR - Francia 23
MX - Messico 19
AR - Argentina 16
ES - Italia 13
IQ - Iraq 13
TR - Turchia 12
PL - Polonia 11
AU - Australia 9
JP - Giappone 9
MY - Malesia 9
PK - Pakistan 9
ZA - Sudafrica 7
NL - Olanda 6
CR - Costa Rica 5
ID - Indonesia 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
PE - Perù 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
DZ - Algeria 4
EC - Ecuador 4
NG - Nigeria 4
PH - Filippine 4
CO - Colombia 3
HN - Honduras 3
JM - Giamaica 3
LV - Lettonia 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RO - Romania 2
TN - Tunisia 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 4.072
Salva come PNG Salva come JPEG
Città #
Singapore 377
Ashburn 271
San Jose 264
Shanghai 158
The Dalles 130
Boardman 108
New York 106
Beijing 89
Helsinki 86
Council Bluffs 85
Dallas 77
Los Angeles 64
Dublin 62
Ho Chi Minh City 41
Santa Clara 36
Hong Kong 34
Milan 32
Hanoi 24
London 24
Naples 23
Falkenstein 21
Moscow 19
Buffalo 18
Pune 17
São Paulo 17
Assago 16
Chennai 16
Chandler 14
Chicago 13
Da Nang 11
Orem 11
Seattle 11
Warsaw 11
Montreal 9
Phoenix 9
Boston 8
Brooklyn 8
Mexico City 8
Shijiazhuang 8
Frankfurt am Main 7
Stockholm 7
Toronto 7
Ankara 6
Denver 6
Dhaka 6
Rio de Janeiro 6
San Francisco 6
Atlanta 5
Baghdad 5
Casal di Principe 5
Charlotte 5
Johannesburg 5
Kuala Lumpur 5
Manchester 5
Wanchai 5
Benin City 4
Guangzhou 4
Hangzhou 4
Lima 4
Mumbai 4
Nairobi 4
Quận Ba 4
Santo André 4
Southwark 4
Sydney 4
Amsterdam 3
Belo Horizonte 3
Cagliari 3
Campinas 3
Dolianova 3
Florence 3
Goiânia 3
Guildford 3
Haiphong 3
Hillsboro 3
Houston 3
Hải Dương 3
Lawrence 3
Luanda 3
Melbourne 3
Montecassiano 3
Munich 3
Pasadena 3
Philadelphia 3
Poplar 3
Presidente Prudente 3
San José 3
St Petersburg 3
São José do Rio Preto 3
Tashkent 3
Thái Nguyên 3
Valencia 3
Vermilion 3
Verona 3
Vũng Tàu 3
Amman 2
Asagayakita 2
Assendelft 2
Athens 2
Auckland 2
Totale 2.567
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 117
COVID-19 in Immunocompromised Patients: A Systematic Review 113
Cardiovascular Complications in Community-Acquired Pneumonia 101
Community-acquired pneumonia 96
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 89
Treatable traits in interstitial lung diseases: a call to action 84
COVID-19 in lung transplant recipients: A case series from Milan, Italy 81
Diagnosis and Initial Investigation of Bronchiectasis 80
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 78
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 75
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 74
COVID-19 multidisciplinary high dependency unit: the Milan model 73
Cardiovascular side-effects of common antibiotics 72
Post-COVID-19 sequelae 71
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 70
What is the best technique to extract bacterial DNA from sputum? 69
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 69
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 68
Comparison of different conditions for DNA extraction in sputum - a pilot study 68
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 68
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study 67
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 67
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 65
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 65
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 64
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 63
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 62
Antibiotics for lung disease and cancer 62
How to Identify Causes and Predisposing Factors in Bronchiectasis 61
Protease-Antiprotease Imbalance in Bronchiectasis 61
Site of care and multidisciplinary approach 60
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity 60
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 60
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 59
Neutrophil elastase in bronchiectasis 59
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 59
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 58
Respiratory failure in COVID-19: a patient's perspective and clinical cases 58
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis 58
Walking the path of treatable traits in interstitial lung diseases 56
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 56
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia 56
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 55
Phenotyping in bronchiectasis: are we moving toward a personalized medicine? 55
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 55
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 54
Treatable Traits in Systemic Sclerosis 53
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 53
The biology of pulmonary exacerbations in bronchiectasis 53
Diagnostic delay in bronchiectasis: an Italian perspective 51
Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series 49
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 48
One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19 47
Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis 46
Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia 46
Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation 46
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 46
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients 45
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 44
Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP 43
Response to: are there over 200 distinct types of interstitial lung diseases? 42
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 41
Glucocorticoid Therapy in COVID-19 39
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study 39
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis 37
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease 36
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 36
Global Variation in Pneumonia Epidemiology 14
Clinical profile and in-hospital outcomes of patients hospitalised for bronchiectasis exacerbation 9
Home-based rehabilitation in interstitial lung disease: picturing the present and drawing the future through a systematic review of the literature 8
Bronchiectasis in Italy: an analysis of the EMBARC registry 8
Accuracy, comprehensiveness and understandability of AI-generated answers to questions from people with COPD: the AIR-COPD Study 6
Totale 4.156
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 2 3 4 2
2022/2023225 4 3 3 5 6 0 63 8 32 63 27 11
2023/2024715 53 64 122 67 32 107 68 31 9 45 50 67
2024/2025906 15 7 17 24 32 105 55 35 204 209 93 110
2025/20262.112 322 130 74 114 130 116 623 95 133 146 80 149
2026/2027187 68 119 0 0 0 0 0 0 0 0 0 0
Totale 4.156